Amgen (AMGN)
$466.01 +1.15% Close Oct 30, 2026 Live
Amgen stock today
Amgen closed at $466.01 on October 30, 2026, up 1.15% on the day. Over the past year it returned +64.0% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $252 billion.
$300.00$400.00
NovJan 2026MarMayJulSep
| Period | AMGN | S&P 500 (SPY) |
|---|---|---|
| 1 month | +10.6% | -0.9% |
| 3 months | +20.9% | +2.1% |
| Year to date | +45.3% | +11.7% |
| 1 year | +64.0% | +12.4% |
| 3 years | +93.7% | +88.5% |
| 5 years | +163.1% | +76.0% |
Key statistics
- Market value
- $252B
- P/E (trailing)
- 29.0
- Forward P/E
- 19.6
- Price / sales
- 6.6
- Dividend yield
- 2.13%
- 52-week range
- $292.00 to $466.01
- Next report
- Nov 3, 2026
About Amgen
Amgen discovers, develops, manufactures, and delivers human therapeutics with a focus on biologics.
Sector: Health Care · Industry: Biotechnology
More on Amgen
- Financials: revenue, earnings and segmentsRevenue +10% in the year to Dec 2025
- Valuation: P/E history and peersP/E 29.0, median 21.8 at its last 10 year ends
- Returns: what $1,000 became$1,000 ten years ago is $4,323 today
No forecast, no recommendation. This page describes Amgen from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.